These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35094739)

  • 1. FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department.
    Mansbridge CT; Tanner AR; Beard KR; Borca F; Phan HTT; Brendish NJ; Poole S; Hill C; Kiuber M; Crouch R; Waddington D; Clark TW
    Infect Control Hosp Epidemiol; 2022 Aug; 43(8):979-986. PubMed ID: 35094739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation.
    Brendish NJ; Davis C; Chapman ME; Borca F; Waddington D; Hill C; White N; Clark TW
    J Infect; 2024 Jan; 88(1):41-47. PubMed ID: 37977337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19.
    Clark TW; Brendish NJ; Poole S; Naidu VV; Mansbridge C; Norton N; Wheeler H; Presland L; Ewings S
    J Infect; 2020 Oct; 81(4):607-613. PubMed ID: 32579983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study.
    Buntine P; Miller J; Pope A; Guy S; Wong FQA; McDonald H; Ahmed M; Teow KH; Roney M; Mohammadi F; Aldridge E; Hackett L; Jenner S; Davis B
    BMJ Open; 2022 Dec; 12(12):e065568. PubMed ID: 36581427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the FebriDx point-of-care test for rapid triage and identification of possible coronavirus disease 2019 (COVID-19).
    Karim N; Ashraf MZ; Naeem M; Anwar T; Aung H; Mallik S; Avraam E; Kiran S; Bandapaati S; Khan F; Tsaknis G; Reddy R
    Int J Clin Pract; 2021 Mar; 75(3):e13702. PubMed ID: 32896946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the FebriDx point-of-care assay in supporting a triage algorithm for medical admissions with possible COVID-19: an observational cohort study.
    Houston H; Deas G; Naik S; Shah K; Patel S; Greca Dottori M; Tay M; Filson SA; Biggin-Lamming J; Ross J; Vaughan N; Vaid N; Gopal Rao G; Amin AK; Gupta-Wright A; John L
    BMJ Open; 2021 Aug; 11(8):e049179. PubMed ID: 34373308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FebriDx host-response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department.
    DiLorenzo MA; Schechter-Perkins EM
    Infect Control Hosp Epidemiol; 2022 Aug; 43(8):1049-1050. PubMed ID: 35491950
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
    Lagi F; Trevisan S; Piccica M; Graziani L; Basile G; Mencarini J; Borchi B; Menicacci L; Vaudo M; Scotti V; Fabbri A; Bandini G; Tozzetti C; Berni A; Aiezza N; Pestelli G; Turchi V; Pignone AM; Poggesi L; Nozzoli C; Morettini A; Rossolini GM; Bartoloni A
    Int J Infect Dis; 2021 Jul; 108():231-236. PubMed ID: 33901656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world evaluation of rapid and laboratory-free COVID-19 triage for emergency care: external validation and pilot deployment of artificial intelligence driven screening.
    Soltan AAS; Yang J; Pattanshetty R; Novak A; Yang Y; Rohanian O; Beer S; Soltan MA; Thickett DR; Fairhead R; Zhu T; Eyre DW; Clifton DA;
    Lancet Digit Health; 2022 Apr; 4(4):e266-e278. PubMed ID: 35279399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study.
    Brendish NJ; Tanner AR; Poole S; Beard KR; Naidu VV; Mansbridge CT; Norton NJ; Wheeler H; Presland L; Clark TW
    Infect Dis Ther; 2022 Jun; 11(3):1267-1280. PubMed ID: 35534764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever.
    Shapiro NI; Self WH; Rosen J; Sharp SC; Filbin MR; Hou PC; Parekh AD; Kurz MC; Sambursky R
    Ann Med; 2018 Aug; 50(5):420-429. PubMed ID: 29775092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency Department Triage in the Era of COVID-19: The Sheba Medical Center Experience.
    Levy Y; Frenkel Nir Y; Ironi A; Englard H; Regev-Yochay G; Rahav G; Afek A; Grossman E
    Isr Med Assoc J; 2020 Aug; 22(8):470-475. PubMed ID: 33236578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FebriDx for rapid screening of patients with suspected COVID-19 upon hospital admission: systematic literature review and meta-analysis.
    Lippi G; Nocini R; Mattiuzzi C; Henry BM
    J Hosp Infect; 2022 May; 123():61-66. PubMed ID: 35202747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid triage for COVID-19 using routine clinical data for patients attending hospital: development and prospective validation of an artificial intelligence screening test.
    Soltan AAS; Kouchaki S; Zhu T; Kiyasseh D; Taylor T; Hussain ZB; Peto T; Brent AJ; Eyre DW; Clifton DA
    Lancet Digit Health; 2021 Feb; 3(2):e78-e87. PubMed ID: 33509388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic.
    Fasola G; Pelizzari G; Zara D; Targato G; Petruzzellis G; Minisini AM; Bin A; Donato R; Mansutti M; Comuzzi C; Candoni A; Sperotto A; Fanin R
    Oncologist; 2021 Apr; 26(4):e694-e703. PubMed ID: 33539583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unenhanced computed tomography (CT) utility for triage at the emergency department during COVID-19 pandemic.
    Skalidis I; Nguyen VK; Bothorel H; Poli L; Da Costa RR; Younossian AB; Petriccioli N; Kherad O
    Am J Emerg Med; 2021 Aug; 46():260-265. PubMed ID: 33046310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions.
    Barnacle JR; Houston H; Baltas I; Takata J; Kavallieros K; Vaughan N; Amin AK; Aali SA; Moore K; Milner P; Gupta Wright A; John L
    J Hosp Infect; 2022 May; 123():92-99. PubMed ID: 35217130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
    Möckel M; Corman VM; Stegemann MS; Hofmann J; Stein A; Jones TC; Gastmeier P; Seybold J; Offermann R; Bachmann U; Lindner T; Bauer W; Drosten C; Rosen A; Somasundaram R
    Biomarkers; 2021 May; 26(3):213-220. PubMed ID: 33455451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of SARS-CoV-2 rapid antigen testing for patient triage in the emergency department: A clinical implementation study in Melbourne, Australia.
    Bond KA; Smith B; Gardiner E; Liew KC; Williams E; Walsham N; Putland M; Williamson DA
    Lancet Reg Health West Pac; 2022 Aug; 25():100486. PubMed ID: 35655473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.